Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CP-118,954

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
&NA; The in vitro inhibition potency against acetylcholinesterase (AChE) of fluorinated derivatives of CP‐118,954 (1) has been… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Acetylcholinesterase (AChE) has been an important cholinergic factor for the diagnosis of Alzheimer's disease (AD), because of… Expand
Is this relevant?
2007
2007
OBJECTIVES Alzheimer's disease (AD) is characterized by reduced acetylcholinesterase (AChE) activity in the post-mortem tissues… Expand
  • figure 1
  • figure 3
  • table 1
  • figure 2
Is this relevant?
2004
2004
OBJECTIVES Acetylcholinesterase (AChE) is an important cholinergic marker for the diagnosis of Alzheimer's disease (AD). A recent… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2002
2002
The selective, reversible acetylcholinesterase inhibitor 5,7-Dihydro-7-methyl-3- [2-[1-(phenylmethyl]-4-piperidinyl]ethyl]-6H… Expand
Is this relevant?
1995
1995
A series of N-benzylpiperidines (2a-d, 10) with novel isoxazole-containing tricycles has been prepared. This series has shown… Expand
Is this relevant?